A new study proved ADHD stimulants do not improve attention but stimulate other parts of the brain. If children don't obtain ...
Millennial Skin on MSN
What ADHD really is—and why so many adults don’t realize they have it
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that affects how the brain regulates ...
Much research on ADHD focuses on the ways that it impairs functioning. A new study, however, illuminates how it may serve as ...
Administering an exam used to be straightforward: All a college professor needed was an open room and a stack of blue books. At many American universities, this is no longer true. Professors now ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Brent D. Griffiths Every time Brent D. Griffiths publishes a story, you’ll get an alert ...
A 3-year-old boy from California is faring well, nine months after becoming the first person to receive a new gene therapy for a rare, life-shortening genetic disorder called Hunter syndrome. Oliver ...
A popular ADHD medication is facing a nationwide recall because tests suggest users will not benefit from the full effect of the drug. The Food and Drug Administration reported on October 28 that ...
A commonly prescribed medication for attention-deficit hyperactivity disorder (ADHD) has been recalled nationwide after failing to meet dissolution standards during laboratory testing. According to an ...
(RTTNews) - Johnson & Johnson (JNJ) on Thursday announced that the U.S. Food and Drug Administration (FDA) has approved Caplyta as an add-on therapy with antidepressants for the treatment of major ...
Johnson & Johnson’s decision to splash out $14.6 billion on its purchase of Intra-Cellular Therapies earlier this year was largely driven by the acquired company's rising antipsychotic star Caplyta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback